Piper Jaffray analyst Matt O'Brien lowered his price target on NuVasive (NASDAQ: NUVA) to $50.00 (from $59.00) following Q4 results ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE